Status:
COMPLETED
Treatment of Upper and Lower Respiratory Tract Infections in Young Children Using Probiotic
Lead Sponsor:
Universiti Sains Malaysia
Collaborating Sponsors:
Beijing Scitop Bio-Tech Shareholding Co.Ltd.
Conditions:
Respiratory Infection (for Example, Pneumonia, Bronchitis)
Eligibility:
All Genders
1-24 years
Phase:
NA
Brief Summary
This project aims to study the benefits of probiotics namely Bifidobacterium lactis M8 in treatment of upper and lower respiratory tract infections in young children, which are found common among chil...
Detailed Description
Respiratory illnesses are the most common acute diseases in children where no virtually effective treatments or prophylaxes are available for these infections. Probiotics on the other hand have gained...
Eligibility Criteria
Inclusion
- young children aged 1-24 month, admitted to hospital for having respiratory diseases.
- Willing to commit throughout the experiment
Exclusion
- Long term medication due to certain severe illness
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Key Trial Info
Start Date :
August 29 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 3 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04122495
Start Date
August 29 2019
End Date
November 3 2020
Last Update
April 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital USM
Kubang Kerian, Kelantan, Malaysia, 16150